Poland’s Ryvu To Feed Galapagos’ R&D Effort

New Drug Target For Anti-inflammatories Identified

 
• By John Davis

Ryvu Therapeutics has added to its drug discovery collaborators with an early-stage deal with Belgium’s Galapagos.     

Poland_Cathedral
Krakow, Where Ryvu Is Based. • Source: Shutterstock

More from Deals

More from Business